Hepatitis C News and Research

Latest Hepatitis C News and Research

Alcohol-linked disease overtakes hep C as top reason for liver transplant

An estimated 17,000 Americans are on the waiting list for a liver transplant, and there's a strong chance that many of them have alcohol-associated liver disease. ALD now edges out hepatitis C as the No. 1 reason for liver transplants in the United States, according to research published Tuesday in JAMA Internal Medicine.

23 Jan 2019

Hepatitis C-infected patients with a history of liver cancer can be treated with antivirals

A large, multi-center study refutes earlier suggestions that antiviral drugs for treating hepatitis C may lead to a higher recurrence of liver cancer.

18 Jan 2019

Combination therapy shows high efficacy in treating people with leishmaniasis and HIV

The results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative, in partnership with Médecins Sans Frontières, the University of Gondar, and Addis Ababa University, open the way for more effective and safer treatments for people with both HIV and visceral leishmaniasis, a group of patients who have historically suffered from poor treatment options.

18 Jan 2019

Many cancer patients have undiagnosed hepatitis

A new report has described an alarmingly high rate of undiagnosed acute and chronic hepatitis B and hepatitis C in patients with cancer.

17 Jan 2019

Research suggests possible way to improve survival in African-Americans undergoing liver transplant

Among African-American adults undergoing liver transplant to treat liver cancer, patients whose organ donor was also African-American lived significantly longer than those with a racially unmatched donor, report authors of a new study using national data.

10 Jan 2019

NYSCF announce partnership with Ngene to develop new disease treatments

The New York Stem Cell Foundation Research Institute today announced a partnership with Ngene Therapeutics Inc. to develop new disease treatments that leverage human stem cell research and novel gene editing techniques.

10 Jan 2019

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Drugs that can cure hepatitis C revolutionized care for millions of Americans living with the deadly liver infection. The drugs came with a steep price tag — one that prompted state Medicaid programs to initially limit access to the medications to only the sickest patients.

4 Jan 2019

Court decision to stop further cuts in 340B reimbursements protects patient care

The Dec. 27 federal court injunction stopping further cuts in 340B reimbursements for Medicare Part B drugs to some participating hospitals is a critical step in preserving the role that academic health centers play in providing HIV, viral hepatitis, and other infectious disease treatment and prevention services to patients who otherwise lack care options.

2 Jan 2019

Himalayan marmot genome offers clues to high-altitude adaptation

Himalayan marmots can survive at altitudes up to 5,000 meters in the Himalayan regions of India, Nepal, and Pakistan and on the Qinghai-Tibetan Plateau of China, where many of them face extreme cold, little oxygen, and few other resources.

27 Dec 2018

Study reveals how Hepatitis C infection varies by state and region

Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.

24 Dec 2018

Researchers synthesize new compound that inhibits replication of hepatitis C virus

A new compound that inhibits the replication of hepatitis C virus in several stages of its lifecycle - and is also capable of acting on bacteria, fungi and cancer cells - has been synthesized by researchers at São Paulo State University in Brazil.

19 Dec 2018

Viral hepatitis: Liver failure caused by defects in the vascular system

In severe cases, a viral hepatitis infection can result in liver failure. A team from the Technical University of Munich has now discovered how this occurs: by immune cells attacking cells in the vascular system, which disrupts the organ's blood and nutrient supply.

19 Dec 2018

Hep C and drug abuse often go hand in hand, but screening for infection lags

When people seek help at a drug treatment center for an opioid addiction, concerns about having contracted hepatitis C are generally low on their list.

19 Dec 2018

Hepatitis C drug can eliminate chikungunya, yellow fever virus

A study performed at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil shows that sofosbuvir, a drug used to treat chronic hepatitis C, is capable of eliminating chikungunya virus and yellow fever virus.

19 Dec 2018

Chronic fatigue syndrome connected with an overactive immune system

A new study has shown that overactive immune systems may be the trigger that gives rise to chronic fatigue syndrome (CFS). The study results were published in the latest issue of the journal Psychoneuroendocrinology.

19 Dec 2018

New drug could significantly slow progression of ALS, shows research

A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.

18 Dec 2018

Study finds new strains of hepatitis C virus in sub-Saharan Africa

The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa.

17 Dec 2018

Research: Myths about migration and health not supported by available evidence

Research published in The Lancet on 5 December revealed that harmful and unfounded myths about migration and health have become accepted and that these are used to justify policies of exclusion.

13 Dec 2018

Study finds drug targets for Ebola, Dengue, and Zika viruses

No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes and UC San Francisco may finally change that. Scientists identified key ways the three viruses hijack the body's cells, and they found at least one potential drug that can disrupt this process in human cells.

13 Dec 2018

RUDN medics first to gather scattered data on hepatitis morbidity in Somalia

Viral hepatitis means liver inflammation caused by viruses and is among top-10 mortality factors in the world. It is passed with contaminated food and water, through contact with infected blood, via common use of household appliances such as manicure or shaving sets.

13 Dec 2018

Hepatitis C News and Research

Latest Hepatitis C News and Research

Alcohol-linked disease overtakes hep C as top reason for liver transplant

Hepatitis C-infected patients with a history of liver cancer can be treated with antivirals

Combination therapy shows high efficacy in treating people with leishmaniasis and HIV

Many cancer patients have undiagnosed hepatitis

Research suggests possible way to improve survival in African-Americans undergoing liver transplant

NYSCF announce partnership with Ngene to develop new disease treatments

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Court decision to stop further cuts in 340B reimbursements protects patient care

Himalayan marmot genome offers clues to high-altitude adaptation

Study reveals how Hepatitis C infection varies by state and region

Researchers synthesize new compound that inhibits replication of hepatitis C virus

Viral hepatitis: Liver failure caused by defects in the vascular system

Hep C and drug abuse often go hand in hand, but screening for infection lags

Hepatitis C drug can eliminate chikungunya, yellow fever virus

Chronic fatigue syndrome connected with an overactive immune system

New drug could significantly slow progression of ALS, shows research

Study finds new strains of hepatitis C virus in sub-Saharan Africa

Research: Myths about migration and health not supported by available evidence

Study finds drug targets for Ebola, Dengue, and Zika viruses

RUDN medics first to gather scattered data on hepatitis morbidity in Somalia

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Hepatitis C News and Research

Latest Hepatitis C News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in